Please assess the completion status of the following clinical trial:

Trial Title: Effectiveness, Immunogenicity and Safety of Meningococcal ABCWY Vaccine Administered to Healthy Adolescents

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Adolescents from 10-18 years of age, generally in good health, and available for all study visits, who/whose legally acceptable representative has given written informed consent at the time of enrollment.~* Female subjects of childbearing potential must have a negative urine pregnancy test.~Exclusion Criteria:~* Serious, acute, or chronic illnesses. Previous or suspected disease caused by N. meningitidis. Previous immunization with any meningococcal vaccine.~* Exposure to individuals with clinically proven meningococcal disease or clinical bacterial meningitis without further microbiologic characterization.

- Gender: ALL
- Minimum Age: 10 Years
- Maximum Age: 18 Years
- Healthy Volunteers: t

Study Arms:
- MenABCWY (Type: EXPERIMENTAL): Subjects received one dose of MenABCWY vaccine at day 1 and a second dose after 2 months
- Placebo/MenACWY (Type: ACTIVE_COMPARATOR): Subjects received one dose of placebo at day 1 and one dose of MenACWY vaccine after 2 months

Based on this trial design, predict the completion outcome and termination type (if applicable).